NDC 21695-137

WELLBUTRIN XL

Bupropion Hydrochloride

WELLBUTRIN XL is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Rebel Distributors Corp. The primary component is Bupropion Hydrochloride.

Product ID21695-137_fdd1fa5e-9dbf-4951-a8e9-33d06e05bdba
NDC21695-137
Product TypeHuman Prescription Drug
Proprietary NameWELLBUTRIN XL
Generic NameBupropion Hydrochloride
Dosage FormTablet, Extended Release
Route of AdministrationORAL
Marketing Start Date2009-12-23
Marketing CategoryNDA / NDA
Application NumberNDA021515
Labeler NameRebel Distributors Corp
Substance NameBUPROPION HYDROCHLORIDE
Active Ingredient Strength150 mg/1
Pharm ClassesAminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 21695-137-45

45 TABLET, EXTENDED RELEASE in 1 BOTTLE (21695-137-45)
Marketing Start Date2009-12-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 21695-137-30 [21695013730]

WELLBUTRIN XL TABLET, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA021515
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-12-23
Inactivation Date2019-09-24

NDC 21695-137-15 [21695013715]

WELLBUTRIN XL TABLET, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA021515
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-12-23
Inactivation Date2019-09-24

NDC 21695-137-45 [21695013745]

WELLBUTRIN XL TABLET, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA021515
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-12-23
Inactivation Date2019-09-24

Drug Details

Active Ingredients

IngredientStrength
BUPROPION HYDROCHLORIDE150 mg/1

OpenFDA Data

SPL SET ID:fdd1fa5e-9dbf-4951-a8e9-33d06e05bdba
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 993557
  • 993541
  • 993564
  • 993545
  • Pharmacological Class

    • Aminoketone [EPC]
    • Dopamine Uptake Inhibitors [MoA]
    • Increased Dopamine Activity [PE]
    • Increased Norepinephrine Activity [PE]
    • Norepinephrine Uptake Inhibitors [MoA]

    NDC Crossover Matching brand name "WELLBUTRIN XL" or generic name "Bupropion Hydrochloride"

    NDCBrand NameGeneric Name
    21695-138WELLBUTRIN XLWELLBUTRIN XL
    21695-137WELLBUTRIN XLWELLBUTRIN XL
    0187-0731WELLBUTRIN XLWELLBUTRIN XL
    0187-0730WELLBUTRIN XLWELLBUTRIN XL
    0115-5445Bupropion HydrochlorideBUPROPION HYDROCHLORIDE
    0115-6811Bupropion HydrochlorideBUPROPION HYDROCHLORIDE
    0185-0410Bupropion HydrochlorideBupropion Hydrochloride
    0185-0415Bupropion HydrochlorideBupropion Hydrochloride
    0185-1111Bupropion HydrochlorideBupropion Hydrochloride
    0173-0135WELLBUTRINbupropion hydrochloride
    0173-0722WELLBUTRINbupropion hydrochloride
    0173-0947WELLBUTRINbupropion hydrochloride
    0173-0556ZYBANbupropion hydrochloride

    Trademark Results [WELLBUTRIN XL]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    WELLBUTRIN XL
    WELLBUTRIN XL
    78103615 2826347 Live/Registered
    GLAXOSMITHKLINE LLC
    2002-01-18

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.